News

Joint research collaboration with Chemical Microscopy, LLC featured in the “Improving Product Quality & Material Understanding” special issue of Pharmaceutical Research

2024-07-26T13:59:00+00:00

WEST LAFAYETTE, Ind., Jan. 26, 2024 /PRNewswire-PRWeb/ -- Research for low-dose therapeutics is a growing trend as promising new highly potent therapeutic agents are developed. Compounds deemed "highly potent" in pharmaceutical pipelines today describe nearly Read more

Joint research collaboration with Chemical Microscopy, LLC featured in the “Improving Product Quality & Material Understanding” special issue of Pharmaceutical Research2024-07-26T13:59:00+00:00

Co-processed Pharmaceutical Solids – A General Introduction by Steve Byrn

2024-01-23T13:25:47+00:00

Co-processed pharmaceutical solids are rising to the forefront as an important concept in pharmaceutical development. This general introduction is the first in a planned series of blogs delving into this exciting area. Schenck and Read more

Co-processed Pharmaceutical Solids – A General Introduction by Steve Byrn2024-01-23T13:25:47+00:00

Joint research collaboration between Merck, Purdue University, Argonne National Laboratory, and Improved Pharma

2024-05-30T16:00:34+00:00

WEST LAFAYETTE, Ind., Nov. 9, 2023 /PRNewswire-PRWeb/ -- Amorphous drugs have become a critical component in modern medicine and in drug development pipelines. Understanding the structural basis of phase stability of these materials is critical in Read more

Joint research collaboration between Merck, Purdue University, Argonne National Laboratory, and Improved Pharma2024-05-30T16:00:34+00:00

Improved Pharma at AAPS 2023 PHARMSCI 360 with booth #3323, two posters, and an invited talk as a Speaker Spotlight

2024-07-26T13:59:11+00:00

WEST LAFAYETTE, Ind., Oct. 10, 2023 /PRNewswire-PRWeb  Starting Monday, October 23rd at 12:30 PM, Dr. Susan-Bogdanowich-Knipp, President of Ravine Pharmaceuticals and Consultant with Improved Pharma, will present "Physical Evaluation of Late Appearing Polymorph of Ritonavir Read more

Improved Pharma at AAPS 2023 PHARMSCI 360 with booth #3323, two posters, and an invited talk as a Speaker Spotlight2024-07-26T13:59:11+00:00

Improved Pharma Enhances Solid-State Analytical Capabilities with Cutting-Edge Empyrean X-ray Diffractometer

2023-10-04T19:59:49+00:00

WEST LAFAYETTE, Ind., Oct. 2, 2023 /PRNewswire-PRWeb/  Improved Pharma is pleased to announce it has recently purchased a Malvern PANalytical Empyrean Multi-Purpose X-ray Diffractometer. This instrument is housed in their new laboratory expansion area and supports their growing Read more

Improved Pharma Enhances Solid-State Analytical Capabilities with Cutting-Edge Empyrean X-ray Diffractometer2023-10-04T19:59:49+00:00

Improved Pharma expands laboratory space by 50% to accommodate recent growth in our research and development programs

2023-09-14T14:37:47+00:00

WEST LAFAYETTE, Ind., Sept. 14, 2023 /PRNewswire-PRWeb/ -- Improved Pharma is pleased to announce it has recently expanded into adjacent laboratory space in the Purdue Kurz Technology Center. This expansion is the second since first acquiring laboratory space Read more

Improved Pharma expands laboratory space by 50% to accommodate recent growth in our research and development programs2023-09-14T14:37:47+00:00

Improved Pharma and Varda Space Industries conducting pharmaceutical experiments in space

2023-06-14T13:39:43+00:00

WEST LAFAYETTE, IND. (PRWEB) JUNE 14, 2023 On board the rocket launch for the Transporter-8 Mission sat Varda’s satellite “W-Series 1”. Within the capsule sits the drug ritonavir, created by scientists at Improved Pharma and housed in engineering Read more

Improved Pharma and Varda Space Industries conducting pharmaceutical experiments in space2023-06-14T13:39:43+00:00

Ritonavir research selected as a top “Remarkable Accomplishment”

2024-07-26T13:59:22+00:00

Improved Pharma is pleased to announce that their ritonavir research with Varda Space Industries that was published earlier this year has been selected by Organic Process Research & Development as one of the top “remarkable accomplishments from the scientific literature that are Read more

Ritonavir research selected as a top “Remarkable Accomplishment”2024-07-26T13:59:22+00:00
Go to Top